Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-03-06 Korenberg Matthew E EVP,Finance & Strategy and CFO Shares withheld for taxes −550 $165.87 $91K 14,215
2018-03-05 LAMATTINA JOHN L Director Option exercise +3,335 $10.12 $34K 24,291
2018-03-05 LAMATTINA JOHN L Director Sale −3,335 $160.90 $537K 20,956
2018-03-05 LAMATTINA JOHN L Director Option exercise · Non-Qualified Stock Option (right to buy) −3,335 0
2018-03-02 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award +1,780 26,839
2018-03-02 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award · Employee Stock Option (right to buy) +9,292 9,292
2018-03-02 HIGGINS JOHN L Chief Executive Officer Grant or award +7,928 104,386
2018-03-02 HIGGINS JOHN L Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +41,392 41,392
2018-03-02 FOEHR MATTHEW W President and COO Grant or award +3,883 99,718
2018-03-02 FOEHR MATTHEW W President and COO Grant or award · Employee Stock Option (right to buy) +20,274 20,274
2018-03-02 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award +3,074 12,761
2018-03-02 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award · Employee Stock Option (right to buy) +16,050 16,050
2018-02-27 Davis Todd C Director Sale −12,335 $151.90 $1.9M 53,563
2018-02-26 Aryeh Jason Director Gift −1,000 58,625
2018-02-26 Davis Todd C Director Sale −4,835 $153.58 $743K 65,898
2018-02-23 Aryeh Jason Director Sale −3,417 $155.00 $530K 86,834
2018-02-23 FOEHR MATTHEW W President and COO Option exercise +1,004 $9.97 $10K 95,835
2018-02-23 FOEHR MATTHEW W President and COO Option exercise +5,444 $14.47 $79K 101,279
2018-02-23 FOEHR MATTHEW W President and COO Sale −5,444 $152.98 $833K 95,835
2018-02-23 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −1,004 42,081

Page 53 of 55 · 1,097 trades